B+
Bull case
20%
Probability
Target price
$36.00
+47.7% vs current
Consensus is mildly positive: median analyst targets sit in the mid-$20s with a wide high/low spread. Near-term sentiment will hinge on earnings, guidance, and any large-client disclosures.
No evidence quality warning is currently attached to this memo.
Quarterly results and guidance will re-price expectations; exact release date not disclosed here so a conservative end-of-window estimate is used.
Material enterprise contract or expansion could accelerate ARR and improve visibility; timing is estimated for pipeline conversion and disclosure windows.
Multi-quarter improvement in net retention and cross-sell could drive margin expansion and multiple re-rating; realization assumed over a longer horizon.
No formal recommendation provided.